$The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia$

The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia

<p><strong>BACKGROUND</strong></p> <p>CD47 is a novel therapeutic target in the treatment of solid‐organ and hematologic malignancies. CD47 is also expressed on RBCs. Here, we report our experience of the RBC effects and the impact on blood bank testing and transfusion...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Brierley, CK, Staves, J, Roberts, C, Johnson, H, Vyas, P, Goodnough, LT, Murphy, MF
Format:	Journal article
Język:	English
Wydane:	Wiley 2019

Podobne zapisy

Mitigating of the interference of anti-CD47 monoclonal antibody on transfusion compatibility detection
od: Yiyang LYU, i wsp.
Wydane: (2023-03-01)

Concepts of blood transfusion in adults.
od: Goodnough, LT, i wsp.
Wydane: (2013)

Do liberal blood transfusions cause more harm than good?
od: Goodnough, LT, i wsp.
Wydane: (2014)

Anti-CD47 monoclonal antibody interferes with compatibility test for blood transfusion:a case report
od: Liuxin TAN, i wsp.
Wydane: (2023-01-01)

Efficacy analysis of transfusion of suspended RBCs and washed RBCs in patients with positive direct Coombs testing results
od: Wenjun QUE, i wsp.
Wydane: (2022-04-01)

Status survey of uncrossmatched type O suspended RBCs in patients with emergency transfusion
od: PENG Zhuoyue, i wsp.
Wydane: (2025-01-01)

How do transfusion services manage patients taking therapies such as anti‐ CD38 and anti‐ CD47 known to interfere with red blood cell compatibility testing?
od: Murphy, MF, i wsp.
Wydane: (2024)

Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model
od: Sean R. Stowell, i wsp.
Wydane: (2015-10-01)

Molecular cloning of RBCS genes in Selaginella and the evolution of the rbcS gene family
od: Wang Bo, i wsp.
Wydane: (2015-01-01)

Commentary: Blood transfusion strategies in elderly patients
od: Murphy, M, i wsp.
Wydane: (2017)

Changing indications for red cell transfusion.
od: Ballard, S, i wsp.
Wydane: (2007)

Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid Leukemia
od: Ruixue Ma BA, i wsp.
Wydane: (2024-10-01)

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia
od: Xuelian Hu, i wsp.
Wydane: (2020-07-01)

Red cell transfusion in haematology: can we reduce usage further?
od: Gooding, S, i wsp.
Wydane: (2009)

Effects of introduction of sorghum RbcS with rice RbcS knockdown by RNAi on photosynthetic activity and dry weight in rice
od: Kazuma Sakoda, i wsp.
Wydane: (2021-07-01)

Patient safety and blood transfusion: new solutions.
od: Dzik, W, i wsp.
Wydane: (2003)

Treatment for Relapsed/Refractory Acute Myeloid Leukemia
od: Felicitas Thol, i wsp.
Wydane: (2021-06-01)

CD47 expression in acute myeloid leukemia varies according to genotype
od: Andrea Marra, i wsp.
Wydane: (2023-06-01)

Acute myeloid leukemia in a patient with constitutional 47,XXY karyotype
od: Marla M. Jalbut, i wsp.
Wydane: (2015-01-01)

TLR3 agonism augments CD47 inhibition in acute myeloid leukemia
od: Haley E. Ramsey, i wsp.
Wydane: (2023-12-01)

Treatment of pediatric relapsed and refractory acute myeloid leukemia
od: F. A. Makhacheva, i wsp.
Wydane: (2023-05-01)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
od: Radhakrishnan Ramchandren, i wsp.
Wydane: (2009-05-01)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
od: James L Gulley, i wsp.
Wydane: (2022-01-01)

Microscopic images dataset for automation of RBCs counting
od: Sherif Abbas
Wydane: (2015-12-01)

Sticky collisions of ultracold RbCs molecules
od: Philip D. Gregory, i wsp.
Wydane: (2019-07-01)

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
od: Stein, EM, i wsp.
Wydane: (2017)

Myeloid pre-leukemia and leukemia of Down syndrome
od: Cruz Hernandez, D, i wsp.
Wydane: (2020)

The impact of electronic decision support and electronic remote blood issue on transfusion practice
od: Hibbs, S, i wsp.
Wydane: (2014)

The impact of electronic decision support and electronic remote blood issue on transfusion practice.
od: Hibbs, S, i wsp.
Wydane: (2014)

Anesthesiologic management of cesarean section at 35-weeks pregnancy with acute myeloid leukemia and profound thrombocytopenia refractory to platelet transfusion: A case report
od: Jemea Bonaventure, i wsp.
Wydane: (2020-01-01)

The risks of red cell transfusion for hip fracture surgery in the elderly.
od: Shokoohi, A, i wsp.
Wydane: (2012)

How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system?
od: Murphy, M, i wsp.
Wydane: (2012)

How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system?
od: Murphy, M, i wsp.
Wydane: (2012)

Platelet Transfusion Refractoriness
od: Anna Mira Lubis MD, i wsp.
Wydane: (2024-09-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
od: E. G. Ovsyannikova, i wsp.
Wydane: (2014-07-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
od: E. G. Ovsyannikova, i wsp.
Wydane: (2014-07-01)

O & M of trickling filters, RBCs, and related processes /
Wydane: (f)

Analysis and prospect of platelet compatible transfusion
od: Faming ZHU, i wsp.
Wydane: (2022-11-01)

Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine
od: Mathilde Gavillet, i wsp.
Wydane: (2012-12-01)

Removing the interference of daratumumab on transfusion compatibility testing and transfusion efficacy comparison
od: Jingdan ZHANG, i wsp.
Wydane: (2024-02-01)